1. Cell Cycle/DNA Damage Apoptosis
  2. Topoisomerase Apoptosis MDM-2/p53 Bcl-2 Family Caspase
  3. Topoisomerase I/II-IN-1

Topoisomerase I/II-IN-1 是 Topoisomerase I/II 的双重抑制剂。Topoisomerase I/II-IN-1 通过上调 p53、p21、Bax mRNA 水平、caspase-3 蛋白水平和 Bax/Bcl-2 比例,并下调 Bcl-2,诱导癌细胞 G2/M 停滞和凋亡 (apoptosis)。Topoisomerase I/II-IN-1 可用于黑色素瘤、肾癌、肠癌、乳腺癌等多种癌症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Topoisomerase I/II-IN-1 Chemical Structure

Topoisomerase I/II-IN-1 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Topoisomerase I/II-IN-1 is a dual inhibitor of topoisomerase I/II. Topoisomerase I/II-IN-1 induces G2/M arrest and apoptosis in cancer cells by upregulating p53, p21, and Bax mRNA levels, caspase-3 protein levels, and the Bax/Bcl-2 ratio, while downregulating Bcl-2. Topoisomerase I/II-IN-1 is useful in the study of various cancers, including melanoma, renal cancer, colorectal cancer, and breast cancer[1].

IC50 & Target[1]

Topoisomerase I

 

Topoisomerase II

 

Caspase 3

 

体外研究
(In Vitro)

Topoisomerase I/II-IN-1 (Compound 5j) (10 μM)对多种癌细胞表现出抑制作用:对黑色素瘤 LOX IMVI 细胞的生长抑制率 (GI) 为 -93.46%,对结直肠癌 HCT-116、HCT-15 和 SW-620 细胞的 GI 分别为 -59.51%、-40.12% 和 -43.01%,对乳腺癌细胞 MDA-MB-468 的 GI 为 -24.45%,对肾癌细胞 786-0、RXF 393 和 UO-31 的 GI 分别为 -11.21%、-12.44% 和 -29.74%[1]

Topoisomerase I/II-IN-1 抑制 Topo I/Topo IIβ 酶活性,在 LOX IMVI 细胞系中的抑制率分别为61.58%/75.51%,在 HCT-116 结肠癌中的抑制率分别为 56.42%/76.39%[1]

Topoisomerase I/II-IN-1 (24小时) 通过上调 HCT-116 和 LOX IMVI 细胞中的 p53、p21、Bax mRNA 水平、裂解的 caspase-3 蛋白水平和 Bax/Bcl-2 比例,并下调 Bcl-2,诱导癌细胞 G2/M 停滞和凋亡[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: HCT-116 and LOX IMVI cells
Concentration: /
Incubation Time: 24 h
Result: Increased the percentage of cells in pre-G1 phase to 34.27%, upregulated the percentage of cells in G2/M phase to 33.32%, and decreased the percentage of cells in S phase to 29.17% in HCT116 cells.
Increased the proportion of cells in the G2/M phase to 27.54%, and decreased the percentage of cells in the S phase to 28.58% in LOX IMVI cells.

Apoptosis Analysis[1]

Cell Line: HCT-116 and LOX IMVI cells
Concentration: /
Incubation Time: 24 h
Result: Decreased the survival rate, which was 0.43% and 0.42%, respectively, and increased the number of necrotic cells, which was 9.22% and 4.88%, respectively, but the number of apoptotic cells was still higher than that of necrotic cells, which was 34.27% and 36.85%, respectively.
分子量

614.62

Formula

C33H31FN4O7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Topoisomerase I/II-IN-1
目录号:
HY-175034
需求量: